Glutamine dipeptide supplementation improves clinical responses in patients with diabetic foot syndrome
AUTOR(ES)
Krupek, Tuane, Silva, Maria Angélica Rafaini Covas Pereira da, Sant´Ana, Débora de Mello Gonçalves, Batista, Márcia Regina, Shimauti, Eliana Litsuko Tomimatsu, Sá-Nakanishi, Anacharis Babeto de, Comar, Jurandir Fernando, Schamber, Christiano Rodrigues, Moreschi Junior, Dorival, Bazotte, Roberto Barbosa
FONTE
Braz. J. Pharm. Sci.
DATA DE PUBLICAÇÃO
2016-09
RESUMO
ABSTRACT The effect of glutamine dipeptide (GDP) supplementation in patients with diabetic foot syndrome was evaluated. A total of 22 patients took part in the study. GDP was supplied in 10 g sachets, and was dissolved in water immediately before use, with ingestion once a day, after lunch or after dinner (20 g/day) over a period of 30 days. Quantification of foot insensitive areas, oxidative stress, blood cytokines, and biochemical, hematological and toxicological parameters was performed before and after GDP supplementation. We observed an increase in blood levels of interferon-α (P=0.023), interferon-γ (P=0.038), interleukin-4 (P=0.003), interleukin-6 (P=0.0025), interleukin-7 (P=0.028), interleukin-12 p40 (P=0.017), interleukin-13 (P=0.001), leukocytes (P=0.037), eosinophils (P=0.049), and typical lymphocytes (P<0.001) due to GDP administration. In addition, we observed a reduced number (P=0.048) of insensitive areas on the foot, and reduction (P=0.047) of fasting hyperglycemia. Patients also showed increased blood high density lipoprotein (P<0.01) and protein thiol groups (P=0.004). These favorable results were associated with the absence of renal and hepatic toxicity. These results are of clinical relevance, since supplementation with GDP over 30 days improved clinical responses in patients with diabetic foot syndrome.
Documentos Relacionados
- Immune Mediators in Patients With Acute Diabetic Foot Syndrome
- Foot Muscle Energy Reserves in Diabetic Patients Without and With Clinical Peripheral Neuropathy
- Penetration of Fosfomycin into Inflammatory Lesions in Patients with Cellulitis or Diabetic Foot Syndrome
- Work ability and productivity in patients with diabetic foot
- Alanyl-glutamine dipeptide-supplemented parenteral nutrition improves intestinal metabolism and prevents increased permeability in rats.